异基可以通过触发热和热来抑制肺癌细胞的生长
Haiyin Fan1, Pengfei Xu1, Bin Zou1
1Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, China.
Nutrition and cancer
|October 20, 2024
概括
异基有效地通过诱导细胞通过亡,热亡和铁亡死亡来抑制肺癌的生长. 这种天然化合物显示出作为肺癌治疗的潜在治疗剂的前景.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 在各种癌症中,异基素表现出抗瘤特性.
- 异quercitrin在肺癌中的特定机制在很大程度上仍未得到研究.
研究的目的:
- 为了研究异quercitrin对人类肺癌细胞的抗癌作用.
- 阐明涉及isoquercitrin作用的潜在机制,包括亡,烧亡和铁亡.
- 在肺癌的临床前小鼠模型中评估异quercitrin的疗效和安全性.
主要方法:
- 试验室研究涉及用异基治疗人类肺癌细胞系和正常的肺上皮细胞,以评估细胞活力,亡,烧亡和铁亡.
- 在体内研究中,使用A549瘤携带的小鼠接受异基素治疗,以评估瘤生长抑制和分子变化.
- 通过使用特定的抑制剂和淘汰技术,研究了关键的分子通路,包括活性氧物种 (ROS) 生成和NLRP3炎症酶激活.
主要成果:
- 伊索克尔林证明了对肺癌细胞的剂量依赖性细胞毒性,而不会影响正常的肺细胞.
- 该化合物显著诱导了肺癌细胞中的亡,NLRP3炎酶介导的亡和铁亡.
- 异quercitrin治疗导致ROS生成的增加,这对亡,烧亡和铁亡至关重要.
- 在体内,异quercitrin抑制了瘤生长,并通过在体内观察到的相同机制促进了癌细胞死亡.
结论:
- 异quercitrin通过激活ROS/NLRP3介导的热和铁来产生抗肺癌作用,而ROS也直接诱导了热.
- 这些发现强调了异基作为肺癌的潜在治疗候选者.
- 需要进一步研究异quercitrin在肺癌中的治疗潜力.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Electron Transport Chain: Complex I and II
12.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.0K
The Electron Transport Chain
16.2K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.2K


